Figure 4From: Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial Estimate of time to progression. Kaplan-Meier graph showing time to progression in percentage of patients randomised (- survival function, + censored): A) all patients; B) subgroup analysis Child A patients; C) subgroup analysis BCLC B patients; D) subgroup analysis BCLC C patients.Back to article page